Leupin Nicolas, former Chief Medical Officer of NovoCure Ltd ($NVCR), made two open market sales of company shares in the last year, totaling nearly $29,000. His most recent sale occurred on March 4, 2026. These transactions rank 10,845th among 11,678 insiders in our database, where the average sale amount is 8.6 million across about 6.4 transactions. Leupin Nicolas recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | NovoCure Ltd | $NVCR | Leupin Nicolas | Former Chief Medical Officer | S | Ordinary Shares | 1100 | $13.31 | 102,979.0000 | 111,981,981 | 1.06% | 0.00% |
| Feb. 27, 2026 | NovoCure Ltd | $NVCR | Leupin Nicolas | Former Chief Medical Officer | S | Ordinary Shares | 1029 | $13.66 | 104,079.0000 | 111,981,981 | 0.98% | 0.00% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | A | Ordinary Shares | 54975 | $18.19 | 105,108.0000 | 109,915,429 | 109.66% | 0.05% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 830 | $19.92 | 50,294.0000 | 109,915,429 | 1.62% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 161 | $20.55 | 50,133.0000 | 109,915,429 | 0.32% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 830 | $19.92 | 50,294.0000 | 109,915,429 | 1.62% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 161 | $20.55 | 50,133.0000 | 109,915,429 | 0.32% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | A | Stock Options (Right to buy) | 78174 | $16.30 | 78,174.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Leupin Nicolas | Chief Medical Officer | A | Ordinary Shares | 51124 | $16.30 | 51,124.0000 | 0 | 9999.99% | 0.00% |